Purdue opioid settlement talks stall over Sacklers’ cash

PURDUE PHARMA's negotiations with state Attorneys General have reportedly stalled. / BLOOMBERG NEWS FILE PHOTO/GEORGE FEY
PURDUE PHARMA's negotiations with state Attorneys General have reportedly stalled. / BLOOMBERG NEWS FILE PHOTO/GEORGE FEY
NEW YORK – Purdue Pharma LP’s settlement talks over the drugmaker’s opioid painkillers have stalled over how much money the family that owns the company is willing to pay, according to people familiar with the negotiations. The Sacklers, Purdue’s owners, have rejected demands by state attorneys general that they guarantee $4.5 billion as part of a…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -